- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
6472
TAI
Week ended 07 Aug 2026
Weekly Investor Report
Bora Pharmaceuticals Co., Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
417.5 TWD
9.2%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -3.3% below the Trend Line and sits at 21.1% of its 52-week range. The latest completed week returned 9.2%, after a 0.6% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
29
out of 100
Latest Close
417.5 TWD
7 Aug 2026
1W Return
9.2%
latest completed week
4W Return
0.6%
short-term follow-through
12W Return
21.4%
quarterly tape
Trend Breadth
21.2%
11 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
9.2%
Latest completed week; four-week move 0.6%.
Indicator stack
12/55
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -3.3% below the Trend Line and sits at 21.1% of its 52-week range. The latest completed week returned 9.2%, after a 0.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0712-week average 0.04
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.07Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.6% over four weeks, 21.4% over 12 weeks, and -37.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year11
Trend breadth21.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.45Latest activity-pressure read.
Pressure change-35.9%Four-week change in activity pressure.
Leadership-42.80Latest relative-leadership reading.
RS change13.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-46.1%Distance below the 52-week high.
13-week volatility7.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+9.2%Week of 7 Aug.
Worst week-15.8%Week of 15 May.
Latest week+9.2%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains4
Flat weeks0
Modest losses6
Sharp losses9
Recent vol7.4%13-week weekly-return volatility.
Base vol5.8%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank18 / 55
Group average-3.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD56.4%positive activity pressure
RS7.3%positive relative leadership
Four-week leaders
IndustryTW Drug Manufacturers - Specialty & Generic
4-week rank4 / 13
Group average-3.1%
Trend breadth23.1%
Trend23.1%active weekly trend signals
MD53.8%positive activity pressure
RS7.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape23/100
Trend, activity pressure, participation, and risk combine to a 23/100 tape read.
Indicator analysis20/100Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.
Activity pressure 0.07; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 417.5 TWD | 9.2% | 431.8 TWD | 557.9 TWD | 0.45 | -42.80 | 3.9M | Off |
| 31 Jul 2026 | 382.5 TWD | 0.1% | 433.9 TWD | 558.7 TWD | 0.46 | -47.43 | 3.4M | Off |
| 24 Jul 2026 | 382.3 TWD | -0.9% | 437.3 TWD | 560.1 TWD | 0.67 | -49.25 | 3.8M | Off |
| 17 Jul 2026 | 385.7 TWD | -7.0% | 440.9 TWD | 560.7 TWD | 0.72 | -48.78 | 5.5M | Off |
| 10 Jul 2026 | 414.9 TWD | -3.1% | 444.2 TWD | 561.4 TWD | 0.70 | -49.31 | 4.7M | Off |
| 3 Jul 2026 | 428.1 TWD | 6.7% | 447.4 TWD | 561.7 TWD | 0.51 | -50.32 | 8.5M | Off |
| 26 Jun 2026 | 401.3 TWD | -2.5% | 450.9 TWD | 561.6 TWD | -0.03 | -52.13 | 7.4M | Off |
| 19 Jun 2026 | 411.5 TWD | 8.2% | 454.4 TWD | 561.8 TWD | -0.42 | -53.88 | 6.4M | Off |
| 12 Jun 2026 | 380.3 TWD | 5.1% | 459.2 TWD | 562.1 TWD | -0.71 | -56.06 | 11.3M | Off |
| 5 Jun 2026 | 361.8 TWD | 7.4% | 466.7 TWD | 562.5 TWD | -0.92 | -59.89 | 4.7M | Off |
| 29 May 2026 | 337.0 TWD | -8.8% | 474.8 TWD | 563.1 TWD | -0.90 | -63.10 | 6.9M | Off |
| 22 May 2026 | 369.6 TWD | 7.5% | 483.9 TWD | 564.0 TWD | -0.96 | -58.00 | 11.3M | Off |
| 15 May 2026 | 343.8 TWD | -15.8% | 492.5 TWD | 564.6 TWD | -1.04 | -60.53 | 11.5M | Off |
| 8 May 2026 | 408.1 TWD | 2.7% | 502.2 TWD | 565.6 TWD | -0.98 | -54.42 | 4.3M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.